08:19 AM EDT, 04/02/2024 (MT Newswires) -- Health care stocks were lower pre-bell Tuesday, with the Health Care Select Sector SPDR Fund (XLV) dropping 1.1% while the iShares Biotechnology ETF (IBB) was down 0.2%.
Verve Therapeutics ( VERV ) slid 35% after the company paused enrollment in its Heart-1 clinical trial after observing "laboratory abnormalities" in one participant.